No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
203 |
4. Check minimum number of eventsNone |
203 |
5. Include endpointsNone |
203 |
6. Filter based on genotype QC (FinnGen only) |
203 |
Control definitions (FinnGen only)
- Control exclude
- AB1_PROTOZOAL
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF5
Similar endpoints
↥List of similar endpoints to
Toxoplasmosis
based on the number of shared cases.
Similar with more cases:
- Protozoal diseases
- Certain infectious and parasitic diseases
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 1599 | 935 | 652 |
| Only index persons | 1392 | 844 | 548 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.02 | 0.03 | 0.02 |
| Only index persons | 0.03 | 0.03 | 0.02 |
| Median age at first event (years) | |||
| Whole population | 31.42 | 32.08 | 30.30 |
| Only index persons | 30.26 | 31.16 | 28.88 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 203 | 131 | 72 |
| Unadjusted period prevalence (%) | 0.04 | 0.04 | 0.03 |
| Median age at first event (years) | 33.49 | 32.08 | 36.06 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 185
- Matched controls
- 1848
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H32.0*B58.0
ICD-10 Finland
Toxoplasma chorioretinitis
+∞
64.4
58
*
B58.9
ICD-10 Finland
Toxoplasmosis, unspecified
+∞
28.9
27
*
13000
ICD-8 Finland
Toxoplasmosis, Acquired
+∞
26.7
25
*
B58.0
ICD-10 Finland
Toxoplasma oculopathy
+∞
22.3
21
*
1302A
ICD-9 Finland
Toxoplasmosis, Chorioretinitis due to toxoplasmosis
+∞
18.0
17
*
13099
ICD-8 Finland
Toxoplasmosis, Unspecified
+∞
16.9
16
*
H32.0
ICD-10 Finland
Chorioretinal inflammation in infectious and parasitic diseases classified elsewhere
185.9
16.8
17
*
S01CA02
ATC
prednisolone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
54.0
13.0
15
*
1309X
ICD-9 Finland
Toxoplasmosis, unspecified
+∞
10.5
10
*
H30.0
ICD-10 Finland
Focal chorioretinal inflammation
+∞
10.5
10
*
S01BA04
ATC
prednisolone; ophthalmic (corticosteroids, plain)
13.2
10.1
17
14
H30.9
ICD-10 Finland
Chorioretinal inflammation, unspecified
+∞
9.4
9
*
H20.0
ICD-10 Finland
Acute and subacute iridocyclitis
7.4
8.3
19
28
Z01.0
ICD-10 Finland
Examination of eyes and vision
3.1
7.6
43
162
XCK10
NOMESCO Finland
Photography of fundus of eye
3.7
7.0
30
91
H30.2
ICD-10 Finland
Posterior cyclitis
72.2
6.5
7
*
H02AB07
ATC
prednisone; oral
3.0
6.4
39
152
S01FA02
ATC
scopolamine; ophthalmic
+∞
6.3
6
*
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
17
16
11.50
15.75
1.5
1.6
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
17
19
9.67
13.97
3.1
3.1
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
10
14
7.46
6.76
1.2
1.2
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
45
229
2.24
4.96
1.2
1.4
titre
348.0
486.0
—
10
60
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
15
42
3.78
4.86
1.4
1.5
iu/ml
0.0
0.1
—
5
6
(4062490)
10
20
5.21
4.83
1.1
1.3
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
14
38
3.88
4.73
1.3
1.2
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
81
530
1.88
4.42
11.2
5.3
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
8
9
9.19
4.32
2.6
1.2
u/ml
1311.1
879.0
—
8
9
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
7
7
10.30
4.04
3.3
1.3
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
42
230
2.04
3.80
3.3
2.2
umol/l
12.6
13.9
0.48
36
211
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
11
30
3.82
3.69
1.0
1.2
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
125
969
1.75
3.65
13.0
9.4
e9/l
4.1
4.1
0.04
110
847
(3026493) Urate [Moles/volume] in Serum or Plasma
65
418
1.82
3.63
2.5
2.6
umol/l
362.0
6205.6
2.02
58
364
(3022096) Basophils/100 leukocytes in Blood
101
741
1.72
3.56
9.8
5.8
%
0.8
0.7
0.37
95
687
(3013115) Eosinophils [#/volume] in Blood
112
846
1.72
3.55
10.7
6.0
e9/l
0.2
0.2
0.12
100
747
(3006315) Basophils [#/volume] in Blood
109
823
1.70
3.41
9.1
5.7
e9/l
0.0
0.0
0.54
96
714
(3019198) Lymphocytes [#/volume] in Blood
111
845
1.69
3.35
9.0
5.7
e9/l
1.9
1.8
0.05
100
750
(3044290) Cell count panel - Cerebral spinal fluid
12
38
3.29
3.27
1.2
1.4
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
108
821
1.67
3.24
9.2
5.7
e9/l
0.6
0.6
0.05
94
711
(3018010) Neutrophils/100 leukocytes in Blood
104
790
1.65
3.08
9.3
5.6
%
57.0
56.9
0.05
99
742
(3004789) Transferrin [Mass/volume] in Serum or Plasma
37
209
1.94
3.05
3.6
2.2
g/l
2.3
2.4
0.82
32
192
(3006504) Eosinophils/100 leukocytes in Blood
101
768
1.63
2.93
9.7
5.7
%
2.6
2.8
0.28
96
714
(3002030) Lymphocytes/100 leukocytes in Blood
104
797
1.63
2.92
9.7
5.8
%
28.6
28.5
0.03
99
744
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
35
198
1.93
2.87
3.8
2.2
%
21.9
22.8
0.13
27
170
(3018418) pH of Serum or Plasma
70
488
1.66
2.85
6.6
4.0
ph
7.4
7.4
0.17
12
88
(3019069) Monocytes/100 leukocytes in Blood
101
775
1.60
2.78
9.9
6.0
%
8.8
8.4
0.70
96
726
(3023368) Bacteria identified in Blood by Culture
57
382
1.68
2.67
7.8
4.2
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
21
102
2.18
2.58
2.9
1.5
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
5
7
7.29
2.56
13.6
2.4
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
5
7
7.29
2.56
13.6
2.4
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
5
7
7.29
2.56
1.2
1.3
u/l
12.6
14.6
—
5
7
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
13
51
2.66
2.49
1.1
2.5
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
10
34
3.04
2.45
1.6
1.4
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
13
52
2.60
2.41
2.2
2.3
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
27
151
1.91
2.30
5.3
3.2
%
1.7
1.9
0.76
21
141
(40758558) Short blood count panel - Blood
61
431
1.59
2.29
11.3
7.5
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
7
18
3.99
2.27
1.0
1.1
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
96
753
1.52
2.26
8.5
6.5
mmol/l
1.2
1.2
0.74
76
632
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
38
240
1.72
2.19
2.7
1.8
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
19
95
2.10
2.19
1.5
2.6
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
7
19
3.78
2.17
1.0
1.2
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
13
55
2.46
2.17
3.5
3.1
g/l
0.1
0.2
—
8
18
(3023410) Appearance of Cerebral spinal fluid
8
25
3.29
2.12
1.4
1.5
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
55
0.00
2.10
0.0
1.6
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
7
20
3.59
2.07
1.0
1.2
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
89
698
1.49
2.05
7.4
5.6
mmol/l
1.2
1.2
1.12
79
635
(3017817) Protein [Mass] in Urine collected for unspecified duration
5
11
4.63
1.95
11.4
4.7
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
144
1253
1.51
1.92
5.0
3.9
mm/h
14.2
10.9
1.49
135
1148
(4306422)
7
22
3.26
1.89
1.0
1.1
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
6
17
3.60
1.85
1.0
1.3
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
5
12
4.24
1.83
1.6
2.6
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
51
363
1.54
1.83
4.3
3.5
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
9
35
2.64
1.82
9.2
1.8
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
61
453
1.50
1.80
4.0
2.7
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
50
357
1.53
1.77
1.5
1.4
g/l
2.3
2.4
0.21
30
223
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
5
13
3.91
1.72
1.8
1.3
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
49
351
1.52
1.70
3.4
2.4
e6/l
7.6
4.6
0.40
44
312
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
14
69
2.11
1.69
1.1
1.0
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
22
128
1.81
1.68
2.0
1.5
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
18
98
1.92
1.68
1.1
1.0
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
8
32
2.56
1.61
1.4
1.3
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
8
32
2.56
1.61
1.9
1.3
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
133
1160
1.43
1.59
5.1
4.1
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
0
44
0.00
1.53
0.0
5.0
—
25.2
—
0
28
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
50
368
1.48
1.52
2.0
1.8
mg/l
1.0
1.1
0.19
37
292
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
6
21
2.91
1.51
1.5
1.8
—
—
—
0
0
(3015736) pH of Urine
81
653
1.40
1.51
3.9
3.3
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
147
1312
1.44
1.49
9.7
7.0
u/l
80.7
76.4
0.56
141
1223
(3009508) Creatinine [Moles/volume] in Urine
63
489
1.42
1.45
3.6
2.8
mmol/l
7.4
7.9
0.37
53
413
(3044941) Cell count panel - Synovial fluid
5
16
3.18
1.44
1.0
1.3
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
34
233
1.55
1.44
3.0
1.9
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
22
136
1.69
1.39
1.2
1.2
—
—
—
0
0
(44790048)
5
17
2.99
1.36
1.4
1.5
—
—
—
0
0
(44790047)
5
17
2.99
1.36
1.4
1.5
—
—
—
0
0
(44790049)
5
17
2.99
1.36
1.4
1.5
—
—
—
0
0
(44806118)
5
17
2.99
1.36
1.4
1.5
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
11
54
2.10
1.35
2.3
1.8
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
39
0.00
1.35
0.0
1.5
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
190
1803
1.84
1.32
21.3
14.5
umol/l
77.5
74.3
0.69
190
1803
(3048689) Calprotectin [Mass/mass] in Stool
32
222
1.52
1.29
1.2
2.1
ug/g
56.2
113.1
1.27
26
180
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
5
18
2.82
1.29
3.2
3.7
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
65
517
1.38
1.28
2.9
2.1
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
8
35
2.34
1.28
1.9
1.3
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
183
1722
1.64
1.28
19.6
12.5
mg/l
24.2
20.7
0.56
148
1335
(3002582) Erythrocytes [#/volume] in Urine
63
499
1.38
1.28
4.2
2.9
e6/l
30.5
167.6
0.54
47
386
(3023520) Reticulocytes [#/volume] in Blood
17
101
1.75
1.24
3.9
3.2
e9/l
62.1
77.2
1.33
12
78
(3018095) Leukocytes [#/volume] in Urine
73
595
1.35
1.23
4.8
3.4
e6/l
86.6
59.8
0.25
51
413
(3012544) pH of Venous blood
20
126
1.65
1.20
6.4
4.1
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
6
26
2.35
1.19
1.0
1.1
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
12
65
1.90
1.16
5.0
9.1
—
—
—
0
0
(4268621)
5
20
2.54
1.16
2.2
1.9
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
5
20
2.54
1.16
1.4
1.5
pg
33.0
32.6
—
5
20
(3030467) Casts [#/volume] in Urine by Automated count
57
451
1.37
1.15
4.1
2.8
e6/l
0.4
0.4
0.04
43
341
(3017143) Hepatitis C virus Ab [Presence] in Serum
29
203
1.50
1.13
2.3
1.6
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
43
326
1.40
1.12
1.8
1.9
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
7
31
2.30
1.11
2.0
1.4
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
7
31
2.30
1.11
1.0
1.5
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
5
21
2.41
1.09
1.2
1.1
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
7
32
2.23
1.09
1.3
1.5
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
7
32
2.23
1.09
1.3
1.5
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
25
171
1.53
1.09
2.6
1.7
—
—
—
0
0
(3008898) HLA-B27 [Presence]
12
67
1.84
1.07
1.0
1.1
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
23
155
1.55
1.07
6.1
7.8
mmol/l
0.6
1.4
0.58
16
117
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
11
60
1.88
1.05
3.6
1.8
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
70
580
1.32
1.04
4.1
2.9
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
50
394
1.36
1.04
1.2
1.3
u/ml
1.2
1.2
—
7
122
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
41
314
1.38
1.01
1.2
1.2
iu/ml
22.6
26.5
0.17
12
112
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
24
166
1.51
1.00
2.5
1.7
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
5
23
2.20
0.98
1.2
1.0
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
9
50
1.84
0.98
10.4
3.5
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
47
371
1.35
0.96
2.5
1.9
mg/l
2.7
3.0
0.38
40
317
(3024561) Albumin [Mass/volume] in Serum or Plasma
80
681
1.29
0.96
6.0
4.5
g/l
34.9
36.1
0.91
74
642
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
0
32
0.00
0.96
0.0
1.7
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
9
51
1.80
0.96
3.9
1.5
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
9
51
1.80
0.96
1.9
1.2
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
19
126
1.56
0.95
1.1
1.2
iu/ml
228.7
101.7
—
8
46
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
7
37
1.92
0.95
2.0
1.6
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
7
37
1.92
0.95
2.0
1.5
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
6
27
2.26
0.94
1.3
1.1
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
10
55
1.86
0.94
1.4
1.4
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
5
102
0.48
0.92
1.4
1.2
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
5
105
0.46
0.91
1.8
1.6
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
37
284
1.37
0.90
4.0
3.2
ng/l
254.4
192.5
0.11
28
216
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
13
79
1.69
0.90
2.5
1.7
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
6
29
2.10
0.90
1.2
5.9
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
6
29
2.10
0.90
3.7
2.4
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
143
1317
1.29
0.88
4.3
4.1
pmol/l
14.7
14.7
0.00
131
1209
(3013139) Helicobacter pylori Ag [Presence] in Stool
15
96
1.61
0.87
1.1
1.2
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
26
189
1.43
0.86
1.3
1.8
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
173
1638
1.38
0.86
4.4
4.4
mmol/l
5.9
5.9
0.07
161
1516
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
80
690
1.26
0.85
2.4
2.4
nmol/l
75.7
76.5
0.08
71
620
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
8
46
1.77
0.83
2.8
1.9
ug/l
145.1
326.4
—
8
41
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
6
32
1.90
0.82
1.3
1.5
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
6
32
1.90
0.82
1.2
1.3
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
44
353
1.31
0.81
1.5
1.6
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
94
830
1.25
0.81
4.5
3.5
estimate
0.0
0.0
0.00
13
172
(3016650) Hepatitis A virus Ab [Presence] in Serum
6
33
1.84
0.79
1.0
1.1
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
94
832
1.24
0.79
5.9
4.8
estimate
0.0
0.0
0.00
13
170
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
10
59
1.73
0.77
3.0
1.9
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
95
844
1.24
0.76
4.5
3.5
estimate
0.0
0.0
0.00
13
164
(3009542) Hematocrit [Volume Fraction] of Blood
168
1592
1.32
0.75
22.9
13.8
%
40.2
40.4
0.12
127
1234
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
5
24
2.11
0.75
1.2
1.4
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
12
181
0.64
0.73
1.3
1.6
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
78
681
1.24
0.73
2.2
2.0
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
58
677
0.80
0.72
2.8
2.7
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
14
93
1.54
0.71
1.4
1.9
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
5
28
1.80
0.66
1.0
1.0
—
—
—
0
0
(3022145) Colonoscopy Study observation
13
188
0.67
0.66
1.0
1.3
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
16
112
1.47
0.66
1.4
1.2
—
23.9
—
0
9
(3012516) Albumin [Mass/volume] in Urine
52
439
1.25
0.65
3.6
3.0
mg/l
124.9
203.9
0.21
32
276
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
5
29
1.74
0.64
4.4
2.9
%
60.6
61.2
—
5
29
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
5
29
1.74
0.64
2.4
1.6
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
5
29
1.74
0.64
4.2
2.3
e9/l
3.7
5.1
—
5
29
(3037756) Immunofixation for Serum or Plasma
5
30
1.68
0.62
1.0
1.7
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
5
30
1.68
0.62
7.2
2.7
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
34
275
1.28
0.60
1.7
1.6
—
—
—
0
0
(40768793) Breast Pathology biopsy report
8
54
1.50
0.58
1.6
1.2
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
6
36
1.69
0.57
1.8
1.4
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
8
55
1.47
0.57
1.6
1.6
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
44
373
1.23
0.54
2.9
2.1
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
17
127
1.37
0.51
2.2
2.2
ml/min/173m2
68.8
70.5
—
6
49
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
164
1571
1.23
0.51
5.1
4.8
mu/l
1.8
1.8
0.06
149
1448
(3000764) Benzodiazepines [Presence] in Urine
11
76
1.47
0.49
2.4
1.3
—
—
—
0
0
(4034850)
7
47
1.51
0.48
5.4
10.2
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
16
120
1.36
0.48
1.6
1.9
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
8
117
0.67
0.47
1.3
1.4
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
195
1912
1.50
0.47
27.4
18.7
e9/l
6.8
6.6
0.75
190
1866
(3024891) Influenza virus A+B Ag [Presence] in Specimen
7
48
1.47
0.47
1.1
1.2
—
—
—
0
0
(40768443) Skin Pathology biopsy report
11
77
1.45
0.46
1.1
1.2
—
—
—
0
0
(3019060) Gas panel - Arterial blood
12
86
1.42
0.45
3.2
4.5
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
11
78
1.43
0.44
2.5
1.3
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
11
78
1.43
0.44
2.5
1.3
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
42
363
1.20
0.43
5.6
3.8
kg/l
1.0
1.0
—
9
46
(3020682) Albumin/Creatinine [Ratio] in Urine
53
468
1.18
0.43
4.2
3.7
mg/mmol
27.2
8.6
0.79
32
285
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
16
205
0.76
0.42
1.6
1.7
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
5
32
1.58
0.42
1.2
2.2
—
—
—
0
0
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
0
15
0.00
0.41
0.0
1.0
—
455.8
—
0
8
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
0
15
0.00
0.41
0.0
1.0
—
273.3
—
0
8
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
0
15
0.00
0.41
0.0
1.1
—
37.3
—
0
8
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(3019225) pH of Specimen
10
137
0.72
0.40
6.0
3.9
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
168
1624
1.20
0.40
3.9
3.8
mmol/l
1.3
1.3
0.27
154
1496
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
174
1688
1.22
0.39
4.2
4.2
mmol/l
1.5
1.5
0.17
160
1566
(3007853) Bacteria identified in Skin by Aerobe culture
22
179
1.26
0.39
2.2
1.5
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
166
1605
1.19
0.38
19.1
11.9
ml/min/173m2
83.1
84.0
0.20
144
1303
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
30
254
1.21
0.38
3.6
2.6
e6/l
1.1
1.1
0.03
16
141
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
21
171
1.25
0.37
1.5
4.2
ug/l
2.2
33.5
0.71
14
146
(4010399)
15
117
1.30
0.36
1.2
1.4
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
54
485
1.15
0.36
1.7
1.6
mmol/l
1.5
1.4
0.38
43
410
(3026008) Bacteria identified in Urine by Culture
53
476
1.15
0.35
4.1
2.9
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
65
593
1.14
0.35
3.5
3.4
ng/l
24.4
26.8
0.16
35
375
(3023511) Choriogonadotropin [Units/volume] in Urine
6
44
1.37
0.34
1.2
1.2
—
—
—
0
0
(3000991) Gas panel - Venous blood
14
109
1.31
0.34
9.9
9.2
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
34
296
1.18
0.33
1.7
1.4
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
83
772
1.13
0.33
18.9
8.6
e9/l
0.0
0.0
1.18
66
629
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
174
1695
1.19
0.32
4.3
4.3
mmol/l
4.6
4.8
0.71
163
1583
(4094501)
6
47
1.28
0.32
1.0
1.1
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
44
393
1.15
0.32
3.5
4.4
ug/l
1.3
1.8
1.77
39
356
(40761536) Microorganisms panel - Urine sediment
18
148
1.24
0.30
4.3
3.3
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
67
618
1.13
0.30
2.2
2.0
pmol/l
106.2
96.1
0.80
35
318
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
176
1719
1.18
0.29
4.7
4.7
mmol/l
2.7
2.8
0.87
162
1594
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
27
233
1.18
0.29
3.8
2.8
e6/l
1.8
2.1
0.20
13
122
(3036481) Cortisol [Moles/volume] in Serum or Plasma
19
158
1.22
0.29
4.7
1.9
nmol/l
349.9
385.8
0.39
19
142
(4035726)
18
149
1.23
0.29
1.7
1.3
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
58
532
1.13
0.28
3.4
3.6
mmol/l
2.4
2.4
0.48
52
469
(1002224) Polysomnography panel
10
76
1.33
0.28
1.0
1.1
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
8
62
1.30
0.28
1.4
1.4
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
8
64
1.26
0.28
2.9
1.3
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
8
67
1.20
0.26
1.3
1.4
mu/l
202.3
284.1
—
8
62
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
24
207
1.18
0.26
1.5
1.5
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
5
72
0.69
0.26
2.0
1.5
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
9
74
1.23
0.25
2.7
1.3
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
10
78
1.30
0.24
1.9
1.3
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
48
522
0.89
0.24
2.9
2.4
u/l
57.9
55.0
0.31
41
483
(3028707) Methadone [Presence] in Urine by Screen method
5
38
1.32
0.23
2.8
1.4
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
5
39
1.29
0.23
1.4
1.5
—
—
—
0
0
(3013512) EKG study
41
448
0.89
0.22
3.2
3.7
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
23
201
1.16
0.22
1.2
1.3
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
5
41
1.22
0.22
1.2
1.3
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
0
12
0.00
0.21
0.0
3.8
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
5
43
1.17
0.21
2.4
4.3
mmol/l
3.9
3.9
—
5
37
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
19.9
—
1835.5
—
0
14
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
45
486
0.90
0.20
1.7
1.5
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
6
49
1.23
0.20
1.3
1.2
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
12
99
1.23
0.20
1.3
1.4
—
—
—
0
0
(3002256) Pathology report gross observation
23
203
1.15
0.20
1.2
1.2
—
—
—
0
0
(3000492) Spirometry study
18
156
1.17
0.19
1.2
1.5
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
6
53
1.14
0.19
2.2
2.0
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
20
176
1.15
0.18
6.7
7.0
mmol/l
104.6
104.0
0.49
20
170
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
31
282
1.12
0.18
2.9
2.8
mmol/l
2.4
2.5
0.57
26
252
(3003327) Ova and parasites identified in Stool by Light microscopy
7
61
1.15
0.17
2.3
1.5
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
5
67
0.74
0.17
1.8
1.5
—
—
—
0
0
(40761535) Cells panel - Urine sediment
14
120
1.18
0.17
5.2
3.4
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
69
656
1.08
0.17
4.8
3.6
—
—
—
0
0
(3022313) Gas panel - Capillary blood
8
73
1.10
0.16
1.8
3.0
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
121
1176
1.07
0.16
3.5
3.3
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
10
84
1.20
0.14
2.3
2.3
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
9
107
0.83
0.13
1.3
1.7
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
183
1810
1.11
0.12
17.0
11.6
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
21
230
0.90
0.12
1.7
2.1
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
41
431
0.94
0.10
3.3
3.0
ng/l
1426.5
1018.4
0.56
35
355
(3022621) pH of Urine by Test strip
10
114
0.87
0.09
5.5
2.7
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
5
47
1.07
0.09
1.4
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
6
55
1.09
0.09
1.5
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
6
56
1.07
0.08
1.5
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
6
56
1.07
0.08
1.5
1.1
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
25
234
1.08
0.08
1.2
1.2
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
5
65
0.76
0.08
1.2
1.5
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
22
205
1.08
0.08
1.5
1.9
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
9
87
1.04
0.07
1.4
1.4
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
48
493
0.97
0.04
4.0
3.0
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
33
319
1.04
0.04
3.1
4.2
%
27.8
21.7
0.59
13
138
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
23
240
0.95
0.03
2.3
2.7
ug/l
0.5
0.8
1.57
16
141
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
79
778
1.03
0.03
4.8
4.0
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
76
750
1.02
0.02
3.8
2.6
ug/l
136.1
105.3
0.70
68
700
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
16
167
0.95
0.01
4.4
3.4
—
—
—
0
0
(3044889) 12 lead EKG panel
116
1166
0.99
0.00
4.1
3.5
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
18
179
1.01
0.00
8.7
6.7
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
45
454
0.99
0.00
5.9
3.7
estimate
0.0
0.0
0.00
12
169
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
25
249
1.00
0.00
1.4
1.7
%
1.4
1.4
0.02
20
218
(3019309) Folate [Moles/volume] in Red Blood Cells
27
271
1.00
0.00
2.3
1.7
nmol/l
1173.0
1185.3
0.03
18
205
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
31
307
1.01
0.00
1.2
1.2
u/ml
7.7
10.1
0.13
12
127
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
158
1575
1.01
0.00
5.0
5.3
mmol/mol
39.1
39.4
0.20
147
1481
(3032080) INR in Blood by Coagulation assay
62
615
1.01
0.00
11.8
7.7
inr
1.2
1.2
0.04
21
185
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
60
595
1.01
0.00
5.2
3.2
u/l
31.5
32.0
0.05
55
569
(3000494) Fungus identified in Specimen by Culture
20
202
0.99
0.00
1.4
1.4
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
0
6
0.00
0.00
0.0
1.0
—
111.7
—
0
6
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3024263) Appearance of Synovial fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
7.1
—
0
6
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
8.1
—
0
6
(3040370) OLANZapine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
168.2
—
0
5
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
0
8
0.00
0.00
0.0
9.0
—
—
—
0
0
(40757494) Bilirubin.total [Moles/volume] in Blood
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
39
390
1.00
0.00
6.0
4.4
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
2.6
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.2
—
31.1
—
0
9
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
6
0.00
0.00
0.0
2.7
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
8
0.00
0.00
0.0
2.6
—
—
—
0
0
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
3.4
—
67.4
—
0
5
(3020891) Body temperature
5
53
0.94
0.00
2.4
4.1
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017704) Immunofixation for Urine
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.2
—
145.4
—
0
9
(3013727) Leukocytes other/100 leukocytes in Blood
0
6
0.00
0.00
0.0
5.8
—
46.5
—
0
6
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
8
0.00
0.00
0.0
2.6
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
5
57
0.87
0.00
2.4
2.2
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
6.0
—
—
—
0
0
(3034426) Prothrombin time (PT)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
(44813793)
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
7
0.00
-0.00
0.0
1.4
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint AB1_TOXOPLASMOSIS and mortality.
Females
No dataMales
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| AB1_TOXOPLASMOSIS | 2.45 [1.73, 3.47] | < 0.001 |
| Birth year | 0.99 [0.98, 1.0] | 0.053 |
During the follow-up period (1.1.1998 — 31.12.2019), 59 out of 345 males with AB1_TOXOPLASMOSIS died.
Mortality risk
Mortality risk for people of age
years, who have AB1_TOXOPLASMOSIS.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | 0.459% |
| 5 | No data | 2.845% |
| 10 | No data | 7.235% |
| 15 | No data | 13.855% |
| 20 | No data | 23.599% |
Relationships between endpoints
↥Index endpoint: AB1_TOXOPLASMOSIS – Toxoplasmosis
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data